Lv51
1240 积分 2023-02-28 加入
Do it
Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trial
19分钟前
待确认
A global phase III randomized controlled trial of etanercept in psoriasis : safety, efficacy, and effect of dose reduction
4天前
已完结
Cutaneous T cell immunity
6天前
已完结
The rewired immune microenvironment in leukemia
14天前
已完结
B cells in non-lymphoid tissues
1个月前
已完结
Innate immune cells in acute and chronic kidney disease
1个月前
已完结
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
2个月前
已完结
A decade of advances in human gut microbiome-derived biotherapeutics
2个月前
已完结
Single-cell analysis in rheumatic and allergic diseases: insights for clinical practice
2个月前
已完结
Surrogate end points in oncology: the speed–uncertainty trade-off from the patients’ perspective
2个月前
已完结
皖公网安备34019202002308
